Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1987;61:492-497

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheldon, R. S.
Right arrow Articles by Duff, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheldon, R. S.
Right arrow Articles by Duff, H. J.

Circulation Research, Vol 61, 492-497, Copyright © 1987 by American Heart Association


ARTICLES

A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels

RS Sheldon, NJ Cannon and HJ Duff
Department of Medicine, University of Calgary, Faculty of Medicine, Alberta, Canada.

We assessed the effects of type I antiarrhythmic drugs on the binding of ligands to receptors on voltage-sensitive sodium channels of rat cardiac myocytes. The radioligand was [3H]batrachotoxinin A 20 alpha- benzoate ([3H]BTXB), a toxin that binds to the sodium channel. The 8 drugs tested inhibited [3H]BTXB binding in a dose-dependent fashion with IC50 values from 1.34 microM for O-demethylencainide to 811 microM for procainamide. A log-log plot of IC50 versus mean therapeutic serum concentration yielded a regression line with slope of 1.17 and r of 0.95. Scatchard analysis of [3H]BTXB binding showed that lidocaine reduced the maximal binding without altering the KD for [3H]BTXB binding, indicating allosteric inhibition. The inhibition by lidocaine of [3H]BTXB binding was reversible within 30 minutes when the samples were diluted from 390 to 39 microM lidocaine. In other studies, the stereoisomers of tocainide were shown to have a threefold to fourfold difference in IC50 for inhibition of [3H]BTXB binding. The binding of antiarrhythmic drugs to this site is saturable, reversible, and stereospecific and occurs at pharmacologically relevant concentrations with similar rank order of potency in vivo and in vitro. This suggests that binding at this site relates to pharmacologic activity.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-F. Xiao, Q. Ke, S.-Y. Wang, K. Auktor, Y. Yang, G. K. Wang, J. P. Morgan, and A. Leaf
Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na+ channels
PNAS, March 1, 2001; (2001) 61003798.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. X. Kang, Y. Li, and A. Leaf
Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n - 3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes
PNAS, March 18, 1997; 94(6): 2724 - 2728.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. X. Kang and A. Leaf
Antiarrhythmic Effects of Polyunsaturated Fatty Acids: Recent Studies
Circulation, October 1, 1996; 94(7): 1774 - 1780.
[Full Text]


Home page
Circ. Res.Home page
H. J. Duff, Z.-P. Feng, and R. S. Sheldon
High- and Low-Affinity Sites for [3H]Dofetilide Binding to Guinea Pig Myocytes
Circ. Res., October 1, 1995; 77(4): 718 - 725.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-F. Xiao, Q. Ke, S.-Y. Wang, K. Auktor, Y. Yang, G. K. Wang, J. P. Morgan, and A. Leaf
Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na+ channels
PNAS, March 13, 2001; 98(6): 3606 - 3611.
[Abstract] [Full Text] [PDF]